ScholarLens Back to search
2011•Fujian yiyao zazhiRequires access

Clinical curative effect of S-Adenosylmethionine in treating chronic hepatitis B with hyperbilirubinemia

Jiang Xiaoya

Open publisher page 0 citations

Abstract

Objective To observe the clinical curative effect of S-Adenosylmethionine(SAMe) in treating chronic hepatitis B with hyperbilirubinemia.Methods To retrospectively analyse 120 cases of chronic hepatitis B patients with hyperbilirubinemia.Sixty cases treated with both glycyrrhizin therapy and SAMe were considered as the treatment group while the other 60 cases treated with only glycyrrhizin therapy as the control group.Serum TBiL,DBiL,ALT,AST,γ-GT and ALP were observed and compared before and two weeks after the treatments.Results After treatments,significant declines in the levels of serum TBiL DBiL ALT and AST were observed in both groups,and also in γ-GT and ALP in the treatment group.The levels of TBiL DBiL ALT AST γ-GT and ALP dropped more in the treatment group than control group.Conclusion SAMe can improve liver function and is a good treatment for chronic hepatitis B with hyperbilirubinemia.

About this research paper

What this paper is about

Objective To observe the clinical curative effect of S-Adenosylmethionine(SAMe) in treating chronic hepatitis B with hyperbilirubinemia.Methods To retrospectively analyse 120 cases of chronic hepatitis B patients with hyperbilirubinemia.Sixty cases treated with both glycyrrhizin therapy and SAMe were considered as the treatment group while the other 60 cases treated with only glycyrrhizin therapy as the control group.Serum TBiL,DBiL,ALT,AST,γ-GT and ALP were observed and compared before and two weeks after the treatments.Results After treatments,significant declines in the levels of serum TBiL DBiL ALT and AST were observed in both groups,and also in γ-GT and ALP in the treatment group.The levels of TBiL DBiL ALT AST γ-GT and ALP dropped more in the treatment group than control group.Conclusion SAMe can improve liver function and is a good treatment for chronic hepatitis B with hyperbilirubinemia.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical curative effect of S-Adenosylmethionine(SAMe) in treating chronic hepatitis B with hyperbilirubinemia.Methods To retrospectively analyse 120 cases of chronic hepatitis B patients with hyperbilirubinemia.Sixty cases treated with both glycyrrhizin therapy and SAMe were considered as the treatment group while the other 60 cases treated with only glycyrrhizin therapy as the control group.Serum TBiL,DBiL,ALT,AST,γ-GT and ALP were observed and compared before and two weeks after the treatments.Results After treatments,significant declines in the levels of serum TBiL DBiL ALT and AST were observed in both groups,and also in γ-GT and ALP in the treatment group.The levels of TBiL DBiL ALT AST γ-GT and ALP dropped more in the treatment group than control group.Conclusion SAMe can improve liver function and is a good treatment for chronic hepatitis B with hyperbilirubinemia.

Key concepts: Glycyrrhizin, Medicine, Gastroenterology, Internal medicine, Liver function, Chronic hepatitis, Liver function tests, Clinical efficacy

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Clinical curative effect of S-Adenosylmethionine in treating chronic hepatitis B with hyperbilirubinemia — Research Paper | ScholarLens